(2-067) Immune-Related and Cutaneous Adverse Events Associated with Relatlimab Mono/Combo Regimens Versus Other Immune Checkpoint Inhibitors in Advanced, Non-Resectable Cutaneous Melanoma: Systematic Review and Meta-Analysis
Monday, December 4, 2023
10:45 AM - 11:45 AM
Location: Hall E, Lower Level
Co-Author(s): Hirra Zaidi, Michelle Anthony, Yaya Edamivoh, Ivo Abraham
